Cargando…

Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing–Remitting Multiple Sclerosis

We aimed to investigate the extent of alterations in the pro/antioxidant balance in the blood of patients with relapsing–remitting multiple sclerosis (RRMS) in relation to drug-modified therapy, gender, disability score, and disease duration. 161 patients (67 men and 94 women, aged 24–69 years, medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bizoń, Anna, Chojdak-Łukasiewicz, Justyna, Budrewicz, Sławomir, Pokryszko-Dragan, Anna, Piwowar, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451869/ https://www.ncbi.nlm.nih.gov/pubmed/37627633 http://dx.doi.org/10.3390/antiox12081638

Ejemplares similares

Evaluation of Selected Oxidant/Antioxidant Parameters in Patients with Relapsing-Remitting Multiple Sclerosis Undergoing Disease-Modifying Therapies
por: Bizoń, Anna, et al.
Publicado: (2022)

Role of Sirtuins in Physiology and Diseases of the Central Nervous System
por: Chojdak-Łukasiewicz, Justyna, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder Treatment—Current and Future Prospects
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Burden of COVID-19 Pandemic Perceived by Polish Patients with Multiple Sclerosis
por: Pokryszko-Dragan, Anna, et al.
Publicado: (2021)

Multimodal Evoked Potentials as Potential Biomarkers of Disease Activity in Patients With Clinically Isolated Syndrome
por: Dziadkowiak, Edyta, et al.
Publicado: (2022)

Monogenic Causes of Strokes
por: Chojdak-Łukasiewicz, Justyna, et al.
Publicado: (2021)

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients
por: Jamroz-Wiśniewska, Anna, et al.
Publicado: (2021)

Cerebral Aneurysms Caused by Atrial Myxoma—A Systematic Review of the Literature
por: Chojdak-Łukasiewicz, Justyna, et al.
Publicado: (2022)

The Level of Stress and Coping Strategies in Patients with Multiple Sclerosis and Their Relationships with the Disease Course
por: Kotas, Roman, et al.
Publicado: (2021)

Migraine and Sleep—An Unexplained Association?
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

The role of ADC values within the normal-appearing brain in the prognosis of multiple sclerosis activity during interferon-β therapy in the 3-year follow-up: a preliminary report
por: Zacharzewska-Gondek, Anna, et al.
Publicado: (2020)

Adherence to Therapy in Patients with Multiple Sclerosis—Review
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2022)

Evaluation of Event-Related Potentials in Assessing Cognitive Functions of Adult Patients with Epilepsy of Unknown Etiology
por: Jeżowska-Jurczyk, Klaudia, et al.
Publicado: (2023)

Quantitative magnetic resonance assessment of brain atrophy related to selected aspects of disability in patients with multiple sclerosis: preliminary results
por: Marciniewicz, Ewelina, et al.
Publicado: (2019)

Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
por: Niepsuj, Justyna, et al.
Publicado: (2022)

Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke—A Dynamic Human LC/MS Metabolomic Study
por: Bladowski, Maciej, et al.
Publicado: (2022)

Psychopathological Symptoms Among Chronically Ill Patients During SARS-CoV-2 Pandemic in Poland
por: Pawłowski, Marcin, et al.
Publicado: (2022)

The Quality of Life and Medication Adherence in Patients with Multiple Sclerosis—Cross-Sectional Study
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2022)

Sleep Disturbances, Degree of Disability and the Quality of Life in Multiple Sclerosis Patients
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2022)

The quality of life in patients with multiple sclerosis – Association with depressive symptoms and physical disability: A prospective and observational study
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2023)

The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2021)

Risk of Short-Term Mortality after Intracerebral Haemorrhage due to Weekend Hospital Admission in Poland
por: Nowakowska-Kotas, Marta, et al.
Publicado: (2020)

Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2011)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing–remitting type of multiple sclerosis
por: Górska, Ewelina, et al.
Publicado: (2023)

Skeletonized mean diffusivity and neuropsychological performance in relapsing‐remitting multiple sclerosis
por: Chylińska, Magdalena, et al.
Publicado: (2022)

Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2023)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Abnormal multisensory integration in relapsing–remitting multiple sclerosis
por: Giurgola, Serena, et al.
Publicado: (2022)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Occult Autoimmune Background for Epilepsy—The Preliminary Study on Antibodies Against Neuronal Surface Antigens
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis
por: Etta, Indu, et al.
Publicado: (2023)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)

Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
por: Gatzonis, Stylianos, et al.
Publicado: (2009)

The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy
por: Adamczyk, Bożena, et al.
Publicado: (2017)

Natalizumab: A new treatment for relapsing remitting multiple sclerosis
por: Hutchinson, Michael
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_afdd3hghtjpp6mbfqqclloogl7